Qube Research & Technologies LTD Nkarta, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.39 - $2.29 $2,900 - $4,779	2,087 New	2,087 $2,000
Q1 2023 May 15, 2023	SELL	$3.37 - $6.3 $565,954 - $1.06 Million	-167,939 Reduced 67.71%	80,102 $284,000
Q4 2022 Feb 14, 2023	BUY	$5.14 - $14.35 $1.27 Million - $3.56 Million	248,041 New	248,041 $1.49 Million
Q2 2022 Aug 15, 2022	BUY	$7.77 - $19.44 $289,587 - $724,528	37,270 New	37,270 $459,000
Q2 2021 Aug 13, 2021	SELL	$23.94 - $36.68 $238,107 - $364,819	-9,946 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$31.33 - $59.61 $311,608 - $592,881	9,946 New	9,946 $327,000

126

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $116M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.